Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06937658 · ClinicalTrials.gov registry record · NA
Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices
A NA study of Implantable Defibrillator User and Pacemaker DDD, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06937658: Recruiting NA study of Implantable Defibrillator User and Pacemaker DDD, sponsored by Beth Israel Deaconess Medical Center.
NCT06937658 is a NA study of Implantable Defibrillator User and Pacemaker DDD that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 120 participants, below the 854-participant average among 5 other Implantable Defibrillator User trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06937658, a NA study of Implantable Defibrillator User and Pacemaker DDD, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The Remote Alert Pathway to Optimize Care of Cardiac Implantable Electrical Devices (RAPTOR-CIED) Study is a pragmatic, multi-center, randomized trial with 1:1 patient-level randomization comparing the safety and effectiveness of alert-driven care versus guideline-based care for patients with wireless cardiac implantable electrical devices (CIEDs). The study will be conducted in 2 phases: a Feasibility Phase and a Main Phase. This registration outlines the goals and design features of the Feasibility Phase of the study.
Primary Outcome
Number of patients enrolled and randomized per site and per month, and cumulatively
Conditions Studied
Interventions
- DEVICE Alert-based care
- DEVICE Guideline-based care
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06937658 shows while recruiting
NCT06937658 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 854-participant average among 5 other Implantable Defibrillator User trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Implantable Defibrillator User appearing as the primary indexed condition, and to 2 interventions - of which Alert-based care is the first listed.
NCT06937658 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06937658 about?
NCT06937658 is a clinical study titled "Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices". The Remote Alert Pathway to Optimize Care of Cardiac Implantable Electrical Devices (RAPTOR-CIED) Study is a pragmatic, multi-center, randomized trial with 1:1 patient-level randomization comparing the safety and effectiveness of alert-driven care versus guideline-based care for patients with wirele...
What is the current status of trial NCT06937658?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-05-01. Estimated completion is 2026-06-30.
What conditions does trial NCT06937658 study?
This clinical trial studies the following conditions: Implantable Defibrillator User, Pacemaker DDD.
What interventions are being tested in trial NCT06937658?
The interventions under investigation include: Alert-based care (DEVICE), Guideline-based care (DEVICE).
Who is sponsoring clinical trial NCT06937658?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06937658 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Implantable Defibrillator User
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Self-Management Interventions After an ICD Shock
RECRUITING · NA
-
Assessment of Combined CCM and ICD Device in HFrEF
ACTIVE NOT RECRUITING · NA
-
A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing MRI, an IDE Study
COMPLETED · NA
-
Effectiveness of Exercise After an ICD
RECRUITING · Phase 2
-
Global Electrical Heterogeneity and Clinical Outcomes
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI